Evaluation of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in cervical cancer: Data from phase 1 and phase 2 studies.
Year: 2021
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Julius Strauss, Fadi S. Braiteh, Emiliano Calvo, Maria De Miguel, Andres Cervantes, William Jeffery Edenfield, Tianhong Li, Marika Anna Rasschaert, Tjoung-Won Park-Simon, Federico Longo, Luis G. Paz-Ares, Alexander I. Spira, Genevieve Jehl, Isabelle Dussault, Laureen S. Ojalvo, James L. Gulley, Suzanne Wendy Allan
Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, Comprehensive Cancer Centers of Nevada, Hospital Universitario HM Sanchinarro, Universitat de València, Prisma Health, UC Davis Comprehensive Cancer Center, Antwerp University Hospital, Medizinische Hochschule Hannover, Instituto Ramón y Cajal de Investigación Sanitaria, Centro de Investigación Biomédica en Red de Cáncer, Hospital Universitario Ramón y Cajal, Hospital Universitario 12 De Octubre, Virginia Cancer Specialists, Merck KGaA, Darmstadt (Germany), EMD Serono, Inc. (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3168043768